STRO.NASDAQSutro Biopharma, INC

4/A: Sutro Biopharma CEO William Newell Corrects Stock Unit Grant in Amended SEC Filing

Sentiment:

SEC Filing

📋All filings for Sutro Biopharma, INC
🔒Login to Follow

William Newell, CEO of Sutro Biopharma, files an amended SEC Form 4 to correct the number of restricted stock units (RSUs) granted on March 5, 2024.

Summary

  • William Newell, the CEO of Sutro Biopharma, filed an amended SEC Form 4 on March 22, 2024, to correct the number of restricted stock units (RSUs) granted to him.
  • The original filing, dated March 7, 2024, has been updated to reflect the accurate number of RSUs.
  • The corrected filing shows that Newell was granted 167,000 RSUs on March 5, 2024.
  • These RSUs vest annually, with 1/4th of the total award vesting each year beginning on March 1, 2025, contingent upon continued service.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing. The correction of the RSU grant is a neutral event, and the vesting schedule is standard practice.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard SEC filing related to executive compensation. It's common for companies to grant stock options or RSUs to executives as part of their compensation packages. These grants are intended to align the executives' interests with those of the shareholders.

Stakeholder Impact

  • The correction of the RSU grant ensures accurate reporting to shareholders.

Key Dates

DateDescription
03/05/2024Date of RSU grant to William Newell.
03/07/2024Date of original Form 4 filing.
03/01/2025First vesting date for the RSUs (1/4th of the total award).
03/22/2024Date of amended Form 4/A filing.
03/01/2028Expiration date of the RSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.